Crescendo Biologics develops novel, targeted T cell enhancing Humabody® therapeutics. Leading its proprietary pipeline is CB307, a CD137 x PSMA bispecific.

ID: 3306971741

linkhttp://crescendobiologics.com calendar_today03-06-2015 11:46:05